Thane Wettig - Nov 13, 2025 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
CEO, Director
Signature
/s/ John Alden, Attorney-in-Fact
Stock symbol
FGEN
Transactions as of
Nov 13, 2025
Transactions value $
$33,750
Form type
4
Date filed
11/17/2025, 04:42 PM
Previous filing
Sep 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wettig Thane CEO, Director C/O FIBROGEN, INC., 350 BAY STREET, SUITE 100, #6009, SAN FRANCISCO /s/ John Alden, Attorney-in-Fact 2025-11-17 0001815638

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Purchase $9.18K +1K +4.71% $9.18 22.2K Nov 13, 2025 Direct
transaction FGEN Common Stock Purchase $24.6K +2.7K +12.14% $9.10 24.9K Nov 17, 2025 Direct
holding FGEN Common Stock 40 Nov 13, 2025 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.